By comparing patients with IBD with and without anti-TNF treatment in a cohort study, Peter et al.4 reported that exposure to TNF inhibitors was associated with a 78% decrease in PD risk (incidence rate ratio 0.22; 95% CI 0.05, 0.88). This evidence concerns the gene TNF and inflammatory bowel disease.